Acute fatty liver of pregnancy

The exact cause is unclear, but acute fatty liver of pregnancy is strongly linked to problems breaking down long chain fats in late pregnancy. This often happens when the baby has a gene change that affects fat processing, and the mother carries the same change. Risk factors for acute fatty liver of pregnancy include a first pregnancy, carrying a male fetus, twins or triplets, preeclampsia, and a past episode. It usually appears in the third trimester or soon after delivery, and lifestyle factors play a smaller role. Talk with your doctor if you’re concerned about your risks.

Genetic risk factors

Acute fatty liver of pregnancy can be triggered by how the fetus processes long‑chain fats. The most established link is when the baby has an inherited problem with breaking down certain fats, which allows toxic byproducts to build up and reach the mother's liver in late pregnancy. Some risk factors are inherited through our genes. For some, early symptoms of acute fatty liver of pregnancy show up in the third trimester when these genetic conditions place extra stress on the mother's liver.

• Fetal LCHAD deficiency: When the baby inherits two changes in the HADHA gene, long‑chain fat byproducts can build up. These cross the placenta and strain the mother's liver, most often late in pregnancy.

• Trifunctional protein defects: Variants in HADHA or HADHB that impair the whole enzyme complex can pose similar risks. The fetus' reduced ability to break down long‑chain fats raises toxic intermediates that affect the mother's liver.

• Maternal carrier status: Many mothers are healthy carriers of a single HADHA or HADHB change without liver disease. Risk rises if the fetus inherits two faulty copies, because the mother's partial processing plus the baby's buildup increases exposure.

• Prior affected pregnancy: A history of acute fatty liver of pregnancy linked to a baby with a fatty acid oxidation disorder suggests higher recurrence in future pregnancies. The chance depends on whether a subsequent fetus inherits the same condition.

• Common HADHA variant: A well‑known change (often called c.1528G>C) is more frequent in some families of Northern European ancestry. Couples who both carry this variant have a higher chance of having a fetus with LCHAD deficiency.

• Other fat-breakdown defects: Rarely, other inherited problems with breaking down long‑chain fats in the fetus have been reported in mothers with acute fatty liver of pregnancy. Evidence is less strong than for LCHAD, but the mechanism is similar.

• Parental relatedness: When parents share recent ancestry, they are more likely to carry the same rare recessive variant. This increases the chance a fetus will inherit two altered copies and, in turn, the mother's risk.

Transmission

Acute fatty liver of pregnancy is not contagious and cannot be passed from person to person. It arises only during pregnancy, and in some families is linked to the baby inheriting changes in a gene that helps break down fats (often called LCHAD), which can raise the mother’s risk of Acute fatty liver of pregnancy in that pregnancy. This is not the genetic transmission of Acute fatty liver of pregnancy itself; rather, when both parents carry the same gene change, the fetus may inherit two copies and create conditions that trigger the mother’s illness. Because of this, recurrence risk can vary between pregnancies, and a genetics visit can clarify how Acute fatty liver of pregnancy is inherited or influenced in families with a fatty acid oxidation condition. There is no need for isolation or precautions around others, since AFLP does not spread.

When to test your genes

Acute fatty liver of pregnancy is genetic/congenital? Not exactly—testing genes isn’t routine for diagnosis. Consider genetic testing if you had AFLP before, had a baby with unexplained newborn liver failure, or there’s suspected fatty‑acid oxidation disorders in the family; results can guide future pregnancy planning and newborn screening.

Looking ahead can feel daunting, but most people with acute fatty liver of pregnancy recover fully after the baby is delivered and the placenta is removed. The key is speed: once AFLP is suspected, delivery—often within hours—usually leads to rapid improvement in liver function over days to a few weeks. In modern hospitals with intensive monitoring, maternal survival now exceeds 90–95%, and most newborns also do well, especially when the condition is caught early. Early care can make a real difference, particularly if complications like severe bleeding, kidney strain, low blood sugar, or infection arise.

Over the next few months, fatigue can linger and lab tests may take time to normalize, but permanent liver damage is uncommon after an AFLP episode. Future pregnancies are possible; however, there is a small chance of recurrence, especially if there’s an underlying genetic issue in the baby’s fatty-acid breakdown. Genetic testing can sometimes provide more insight into prognosis. If a prior pregnancy involved AFLP, many clinicians recommend preconception counseling, a delivery plan at a hospital with high-level obstetric and newborn care, and close watch for early symptoms of acute fatty liver of pregnancy in the third trimester.

For most families, long-term health returns to baseline once recovery is complete, and life expectancy is not reduced when AFLP is promptly treated. Rarely, severe cases can be life threatening if diagnosis or delivery is delayed, which is why urgent evaluation for persistent nausea, abdominal pain, jaundice, or confusion in late pregnancy matters. Talk with your doctor about what your personal outlook might look like.

Acute fatty liver of pregnancy is treated in the hospital because it can worsen quickly for both parent and baby. The main treatment is prompt delivery once you’re stable, often within 24–48 hours, since the condition is tied to late pregnancy and usually improves after the baby is born. In the meantime, doctors focus on supportive care: IV fluids, careful blood sugar control, vitamins like thiamine, and treatments to correct bleeding and liver-related problems; you might receive plasma or platelets if clotting is low, and antibiotics if infection is suspected. Your care team may include obstetrics, liver, anesthesia, and newborn specialists, and you’ll be closely monitored in a high‑dependency or intensive care unit; Supportive care can make a real difference in how you feel day to day. After delivery, most people recover over days to weeks, but follow-up blood tests and, in some families, genetic counseling for fatty‑acid oxidation conditions may be recommended.

Genetics can play a role in acute fatty liver of pregnancy, most often through a rare condition in the baby that affects how fats are broken down. If the fetus has a fatty‑acid oxidation disorder (such as LCHAD deficiency), certain fat byproducts can build up and stress the mother’s liver in late pregnancy. In these families, both parents are usually healthy carriers of the gene change, and the fetus inherits two copies. A “carrier” means you hold the gene change but may not show symptoms. After an episode of acute fatty liver of pregnancy, genetic testing for acute fatty liver of pregnancy usually means checking the newborn and parents for fatty‑acid oxidation disorders, rather than a test of the mother’s liver itself. The chance of AFLP happening again may be higher if both partners carry the same gene change; with a different partner, the risk can be lower. Genetic counseling can help you understand your family’s results and plan for future pregnancies, including options for screening in early pregnancy.

Acute fatty liver of pregnancy (AFLP) can occur in the same pregnancy as high blood pressure disorders such as preeclampsia or HELLP syndrome, and their signs often overlap. Having more than one diagnosis can make symptoms feel harder to untangle. Early symptoms of acute fatty liver of pregnancy—nausea, tiredness, and pain high in the belly—can look a lot like HELLP or severe preeclampsia, and when they happen together the risks of kidney injury, bleeding problems, and low platelets tend to be higher. AFLP can also come with pancreatitis, severe infection, or low blood sugar, which may intensify liver stress and make recovery slower. Other liver conditions, including viral hepatitis, can exist at the same time and further impair liver function, so clinicians usually test broadly to sort out what’s contributing. AFLP is linked to a fetal fatty‑acid breakdown problem (often a variant called LCHAD deficiency), so a history of babies with unexplained low blood sugar, liver trouble, or sudden illness may hint at overlapping risks in future pregnancies and is worth discussing before a next pregnancy.

How genes can cause diseases

Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.

Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.